Responses
Poster Presentations
Epidemiology, health services and outcome research
THU0623 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib in Patients with Early Rheumatoid Arthritis Who Had Received Limited or No Treatment with Disease-Modifying anti-Rheumatic Drugs
Compose a Response to This Article
Other responses
No responses have been published for this article.